Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of FLUAD 2009-2010 influenza vaccine in elderly subjects
2009-010586-23Phase 2Completed
- Sponsor
- Novartis
- Start
- Apr 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Fluzone Trivalent in influenza, sponsored by Novartis. Primary endpoints: Antibody response by single radial hemolysis at Day 21 and Safety of a single intramuscular injection of FLUAD. Started Apr 2009; status: completed.
02
Drugs
Fluzone Trivalent
03
Conditions
influenza
Beyond the preview
Go deeper on 2009-010586-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010586-23.